Navigation Links
American Heart Association Announces Next New Journal - Circulation: Heart Failure Set for May Premier
Date:5/7/2008

of heart failure. Circulation: Heart Failure will present high-quality, rigorously performed studies in clinical and translational science, as well as basic research articles with potential implications for the field. Recurring features will address the latest topics and controversies in heart failure, the development of new drugs and devices, and case reports and imaging studies of interest to clinicians involved in treating heart failure.

Circulation: Heart Failure is the second of the new Circulation portfolio of journals, designed to meet the growing demand for tightly focused information in areas at the cutting edge of cardiology. Circulation: Arrhythmia and Electrophysiology premiered recently. The remaining four titles -- Circulation: Cardiovascular Genetics; Circulation: Cardiovascular Imaging; Circulation: Cardiovascular Quality and Outcomes; and Circulation: Cardiovascular Interventions -- are scheduled for launch later in 2008.

Each issue of Circulation: Heart Failure and the other new journals will be available in both print and online formats. The journal Web site, http://circheartfailure.ahajournals.org, will launch next week when the first issue is posted and will also present "Publish Ahead of Print" articles and other online features.

American Heart Association/American Stroke Association Premium Professional members will have free, full-text access to journal articles through December 31, 2008. The first issue of each of the six new journals will be available to the public for free as sample issues.

About the American Heart Association

Founded in 1924, the American Heart Association is the nation's oldest and largest voluntary health organization dedicated to building healthier lives, free of heart disease and stroke. These diseases, America's No. 1 and No. 3 killers, claim more than 870,000 lives a year. In fiscal year 2006-07 the as
'/>"/>

SOURCE American Heart Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
6. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
7. Novo Nordisk Appoints New Leader of North American Business
8. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
9. Primary biliary cirrhosis more severe in African-American and Hispanic patients
10. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
11. American Chemical Societys Weekly Presspac -- Sept. 5, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ty of Michigan determined that only 663,000 of the...s C virus (HCV) infection received antiviral thera...to be declining, in part because only half of the ...ng trend continues, by 2030 less than 15% of liver...viral therapy. This study, the first to analyze n...
(Date:11/23/2009),, NEWYORK,Nov.23/PRNewswire/--Livingwithchronicpaincanbedifficult-andthestressoftheholidayseasoncanprovetobequitechallengingforthoselivingwithpain. ,, ListentothisreportfromPfizerInc.at: ,
(Date:11/23/2009)...ok for the high cost of drug advertising that does...ed by a University of British Columbia health poli...the Archives of Internal Medicine , examined the ...ug also known by the trade name Plavix used to pre... drug was selected to study the impact of advertis...
(Date:11/23/2009)... suffering from women,s hair loss for almost ten y...he,s sharing her progress and the secret behind he...e release of her video diaries which include a dir...reatment. , (PRWeb UK) No...Zsanett Siklosi has released the video diaries tha...
(Date:11/23/2009)...n might ease the problem, researchers say , ...bottle up their anger over unfair treatment at wor...dy indicates. , Men who consistently failed to ...low worker or supervisor were more than twice as l...se as those who vented their anger, claims a repor...
Breaking Medicine News(10 mins):Health News:Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US 2Health News:Drug ads ineffective for boosting sales, could cost taxpayers: UBC-Harvard study 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3
...opene, other nutrients no shield against prostate ...14 (HealthDay News) -- Men who,ve been adding vita...ts to cut their risk of prostate cancer may need t...odds of prostate malignancy -- findings that are i...
...T LAKE CITY, Sept. 14 Dynatronics,Corporation (Na...th quarter,and fiscal year ended June 30, 2007. Ne...943 ($.02 per share), compared to $39,101 ($.00 pe...r the year ended June 30, 2007 were $17,837,104, c...
...NDALE, Mich., Sept. 14 Nearly 300 of,Detroit,s mo...f art to be,auctioned at the twelfth annual "ART W...5:00 p.m. on Sunday, September 23, 2007 at The Rit...tioneer Jim Miller, hors d,oeuvres, a cash bar, va...
...ANN ARBOR, Mich.---Using atom-level imaging techni...aled important structural details of an enzyme sys...ole in helping the body efficiently break down man...es. , The system involves two proteins that work ...
...Many sets of guidelines and regulations, and great...l researchers encounter if they want to use previo...arch. For one thing, this makes it extremely comp... (CBE), together with leading biobank researchers,...
...g-Term Outlook More Favorable as Drugs from Eli Li... 2016, According to a New Report ...pt. 12 Decision Resources, one of the,world,s lea...Astellas,s Flomax/Harnal, combined with the limite...
Other Medicine News:Health News:Tomato Diet Can't Guarantee Prostate Health: Study 2Health News:Tomato Diet Can't Guarantee Prostate Health: Study 3Health News:Tomato Diet Can't Guarantee Prostate Health: Study 4Health News:Dynatronics Announces Strong Fourth Quarter Profit 2Health News:Dynatronics Announces Strong Fourth Quarter Profit 3Health News:Revealing the workings of 'Mother Nature's blowtorch' 2Health News:Long-awaited international ethical guidelines for biobank researchers 2Health News:Patent Expiries of Proscar and Flomax/Harnal Will Cause a Significant Decline in Near-Term Sales of Benign Prostatic Hyperplasia Drugs 2
(Date:11/23/2009)...wswire-FirstCall/-- LexiconPharmaceuticals,Inc. (N...sPhase2clinicalstudywith LX1031 inpatientswithnon-...ntedatGASTRO2009inLondonthisweek.Resultsfromthestu...,willbepresentedbyDr. PhilipM.Brown ,Lexicon,sseni...2009at2:30pmlocaltimeatthesessionentitled,"Therape...
(Date:11/23/2009)...ire-FirstCall/--WoundManagementTechnologies,Inc.,(...cialtymedicalproducts,announcedthatithasfileditQ32...agementbusinessupdatetoillustratethedevelopmentsdu...ed33.5%to$102,926vs.Q32008salesof$77,084. , S...vs.Q32008shareholderequityof$(321,257) , Tota...
(Date:11/23/2009)...3/PRNewswire-FirstCall/--Anesiva,Inc.(Nasdaq: ANSV...chardhaveagreedtojointheAnesivaboardofdirectorsfol...ndArcionTherapeutics.Completionofthemergerissubjec...uslyannouncedAnesiva2009AnnualMeetingofStockholder...Point,Suite107A,SouthSanFrancisco,California,among...
Breaking Medicine Technology:Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3OcumatRx Announces Promising Clinical Trial Results for Implant with Potential to Permanently Treat Glaucoma 54336 1OcumatRx Announces Promising Clinical Trial Results for Implant with Potential to Permanently Treat Glaucoma 54336 2OcumatRx Announces Promising Clinical Trial Results for Implant with Potential to Permanently Treat Glaucoma 54336 3Pennsylvania Patient Safety Authority Marks Milestone With One Million Reports 54332 1Pennsylvania Patient Safety Authority Marks Milestone With One Million Reports 54332 2Pennsylvania Patient Safety Authority Marks Milestone With One Million Reports 54332 3Pennsylvania Patient Safety Authority Marks Milestone With One Million Reports 54332 4Perfect Fitness Ranks No 1 of Consumer Product Companies on 2009 Inc 500 List Ranks No 4 Overall 54327 1Perfect Fitness Ranks No 1 of Consumer Product Companies on 2009 Inc 500 List Ranks No 4 Overall 54327 2
...w Subset Analyses To Be Presented --, SAN FRANCISC...tion, Inc. today announced that data from the Comp...heimer,s disease will be,presented for the first t...f Neurology,s 59th Annual Meeting in Boston on Thu...ntation will include new,data from both the mild a...
...R--(BUSINESS WIRE)--Apr 24, 2007 - Ceragenix Pharm...ive results from its,post-clearance marketing stud...ivate(R) cream, a mid-strength topical steroid in ...tis (AD)., The study, which took place at five cen... patients receiving treatment with,Cutivate(R) and...
Other Medicine Technology:Medivation Announces First U.S. Presentation of Data From Dimebon,Phase 2 Alzheimer's Disease Trial at American Academy of Neurology,Annual Meeting 2Medivation Announces First U.S. Presentation of Data From Dimebon,Phase 2 Alzheimer's Disease Trial at American Academy of Neurology,Annual Meeting 3Ceragenix Announces Results from Phase IV Study of EpiCeram Meet,All Primary and Secondary Endpoints 2Ceragenix Announces Results from Phase IV Study of EpiCeram Meet,All Primary and Secondary Endpoints 3Ceragenix Announces Results from Phase IV Study of EpiCeram Meet,All Primary and Secondary Endpoints 4Ceragenix Announces Results from Phase IV Study of EpiCeram Meet,All Primary and Secondary Endpoints 5Ceragenix Announces Results from Phase IV Study of EpiCeram Meet,All Primary and Secondary Endpoints 6
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: